Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Zur Rose Group AG
  6. News
  7. Summary
    ROSE   CH0042615283

ZUR ROSE GROUP AG

(ROSE)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 12/01 06:03:31 am
346.75 CHF   -0.64%
11/26ZUR ROSE : EHealth-Tec achieves first place in the TOP 100 competition
PU
11/25ZUR ROSE GROUP : Jefferies reiterates its Buy rating
MD
11/05ZUR ROSE GROUP : Jefferies maintains a Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Zur Rose Group continues to grow -2-

10/21/2021 | 12:57am EST

With its business model, the Zur Rose Group offers high-quality, safe and cost-effective pharmaceutical care. It also excels in continuous development of digital healthcare services and as a platform technology provider. In addition, Zur Rose is actively driving forward its positioning as a comprehensive healthcare service provider, with focus on building up its European healthcare ecosystem networking qualified providers of products, services and digital solutions. Zur Rose's contribution will be to bring these offerings to customers and patients, pursuing its vision of creating a world where people can manage their own health in one click.

The shares of Zur Rose Group AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker ROSE). For further information, please visit zurrosegroup.com.

^[1] External revenue consists of the consolidated revenue of the Zur Rose Group plus the mail-order revenue of pharmacies supplied by the Zur Rose Group, less the consolidated revenue for their supply. ^[2] Customers supplied by the Zur Rose Group, either directly or through its partners.

-----------------------------------------------------------------------------------------------------------------------

End of ad hoc announcement

-----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      Zur Rose Group AG 
              Walzmühlestrasse 60 
              8500 Frauenfeld 
              Switzerland 
Phone:        +41 52 724 08 14 
Internet:     www.zurrosegroup.com 
ISIN:         CH0042615283 
Listed:       SIX Swiss Exchange 
EQS News ID:  1242276 
 
End of Announcement EQS Group News Service 
=------------ 

1242276 21-Oct-2021 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1242276&application_name=news

(END) Dow Jones Newswires

October 21, 2021 00:56 ET (04:56 GMT)

All news about ZUR ROSE GROUP AG
11/26ZUR ROSE : EHealth-Tec achieves first place in the TOP 100 competition
PU
11/25ZUR ROSE GROUP : Jefferies reiterates its Buy rating
MD
11/05ZUR ROSE GROUP : Jefferies maintains a Buy rating
MD
10/28Roche, Zur Rose Partner for Diabetes Management Project
MT
10/28Roche and the Zur Rose Group announce collaboration to offer innovative health journeys..
PU
10/25ZUR ROSE GROUP : Gets a Sell rating from UBS
MD
10/22ZUR ROSE GROUP : Baader Bank maintains a Buy rating
MD
10/22ZUR ROSE GROUP : UBS maintains a Sell rating
MD
10/22ZUR ROSE GROUP : Receives a Buy rating from Warburg Research
MD
10/21ZUR ROSE GROUP : Jefferies reiterates its Buy rating
MD
More news
Analyst Recommendations on ZUR ROSE GROUP AG
More recommendations
Financials
Sales 2021 1 716 M 1 865 M 1 865 M
Net income 2021 -158 M -172 M -172 M
Net Debt 2021 388 M 422 M 422 M
P/E ratio 2021 -22,0x
Yield 2021 -
Capitalization 3 347 M 3 630 M 3 639 M
EV / Sales 2021 2,18x
EV / Sales 2022 1,59x
Nbr of Employees 1 960
Free-Float 88,2%
Chart ZUR ROSE GROUP AG
Duration : Period :
Zur Rose Group AG Technical Analysis Chart | ROSE | CH0042615283 | MarketScreener
Technical analysis trends ZUR ROSE GROUP AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 349,00 CHF
Average target price 442,63 CHF
Spread / Average Target 26,8%
EPS Revisions
Managers and Directors
Walter Oberhänsli Chief Executive Officer & Executive Director
Marcel Ziwica Chief Financial Officer
Stefan Feuerstein Chairman
Madhu Nutakki Chief Technology Officer
Bernd Michael Gschaider Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZUR ROSE GROUP AG23.32%3 630
WALGREENS BOOTS ALLIANCE, INC.12.34%38 779
MCKESSON CORPORATION24.63%33 095
JD HEALTH INTERNATIONAL INC.-54.67%27 790
CARDINAL HEALTH, INC.-13.69%13 027
WELCIA HOLDINGS CO., LTD.3.34%7 396